Wells Fargo analyst Timothy Daley lowered the firm’s price target on Labcorp to $270 from $290 following quarterly results. The firm keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LH:
- American downgraded, United upgraded: Wall Street’s top analyst calls
- BofA starts Labcorp spinoff Fortrea with an Underperform
- Labcorp announces partnership with Tufts Medicine
- Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
- Labcorp price target lowered to $231 from $247.41 at Credit Suisse
